NCT03634514View on ClinicalTrials.gov

Non-inferiority Evaluation of Pain Intensity After Biomatrop (Somatropin) Application in Relation to Hormotrop (Somatropin), in Healthy Subjects

PHASE4UnknownINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

August 27, 2018

Primary Completion Date

September 30, 2018

Study Completion Date

October 31, 2018

Conditions
Healthy Subjects
Interventions
DRUG

Recombinant human growth hormone - Biomatrop

The subjects who recieve Biomatrop first, after a period maximum of 24 hours will recieve a dose of Hormotrop.

DRUG

Recombinant human growth hormone - Hormotrop

The subjects who recieve Hormotrop first, after a period maximum of 24 hours will recieve a dose of Biomatrop.

Trial Locations (1)

Unknown

Instituto de Ciências Farmacêuticas, Goiânia

Sponsors
All Listed Sponsors
lead

Ache Laboratorios Farmaceuticos S.A.

INDUSTRY